Allicin and Cancer Hallmarks
Molecules · 15.03.2024 · 29 (6) · 1320
DOI: 10.3390/molecules29061320 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 15.03.2024. Verfasst von Wamidh H Talib und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Applied Science Private University, Amman 11931, Jordan. Hauptthemen laut MEDLINE: Plants, Medicinal, Antineoplastic Agents, Colonic Neoplasms, Garlic. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Science Private University, Amman, Jordan.
Abstract (Originalsprache)
Natural products, particularly medicinal plants, are crucial in combating cancer and aiding in the discovery and development of new therapeutic agents owing to their biologically active compounds. They offer a promising avenue for developing effective anticancer medications because of their low toxicity, diverse chemical structures, and ability to target various cancers. Allicin is one of the main ingredients in garlic (Allium sativum L.). It is a bioactive sulfur compound maintained in various plant sections in a precursor state. Numerous studies have documented the positive health benefits of this natural compound on many chronic conditions, including gastric, hepatic, breast, lung, cervical, prostate, and colon cancer. Moreover, allicin may target several cancer hallmarks or fundamental biological traits and functions that influence cancer development and spread. Cancer hallmarks include sustained proliferation, evasion of growth suppressors, metastasis, replicative immortality, angiogenesis, resistance to cell death, altered cellular energetics, and immune evasion. The findings of this review should provide researchers and medical professionals with a solid basis to support fundamental and clinical investigations of allicin as a prospective anticancer drug. This review outlines the anticancer role of allicin in each hallmark of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Applied Science Private University, Amman 11931, Jordan.
- Department of Clinical Pharmacy and Therapeutics, Applied Science University, Amman 11931, Jordan.
- Department of Health Sciences, College of Natural and Health Sciences, Zayed University, Abu Dhabi 144534, United Arab Emirates.
ORCID-Profile: Wamidh H Talib, Media Mohammed Baban, Lina T Al Kury
Förderung
- Applied Science Private University, Amman, Jordan
Zitieren
APA
Talib, W. H., Baban, M. M., Azzam, A. O., Issa, J. J., Ali, A. Y., AlSuwais, A. K., Allala, S., & Al Kury, L. T. (2024). Allicin and Cancer Hallmarks. Molecules, 29(6), 1320. https://doi.org/10.3390/molecules29061320
Vancouver
Talib WH, Baban MM, Azzam AO, Issa JJ, Ali AY, AlSuwais AK, et al. Allicin and Cancer Hallmarks. Molecules. 2024;29(6):1320. doi:10.3390/molecules29061320
BibTeX
@article{Talib2024,
author = {Talib, Wamidh H and Baban, Media Mohammed and Azzam, Aya O and Issa, Jenan J and Ali, Alaa Y and AlSuwais, Alia Kh and Allala, Sana and Al Kury, Lina T},
title = {Allicin and Cancer Hallmarks},
journal = {Molecules},
year = {2024},
volume = {29},
number = {6},
pages = {1320},
doi = {10.3390/molecules29061320}
}
EUVIMED